A Study of Effect of Selpercatinib (LY3527723) in Participants With Normal and Impaired Renal Function

NCT05469100 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy
Renal Insufficiency

Interventions

DRUG: Selpercatinib

Sponsor

Eli Lilly and Company

Collaborators

[object Object]